News

Press Release: Biograil and Lilly Sign Collaboration and License Agreement
Biograil has signed a Collaboration and License Agreement with Eli Lilly
October 4, 2022
Read more
Press Release: Biograil Receives Innobooster Grant Providing Non-dilutive funding for BIONDDTM Technology Research and Activities in Preparations for Phase 1 clinical trials
Biograil recieves granting of government funds from Innobooster
March 14, 2022
Read more
Press Release: Biograil Forms International Scientific Advisory Board with Diverse Expertise to Support Further Optimization of the proprietary BIONDDTM Technology
After achieving proof of concept of BIONDDTM Technology in a pre-clinical model
March 1, 2022
Read more
Press Release: Biograil Secures Seed 2 Funding for Oral Delivery Device for Biologics
Biograil closing of a Seed 2 funding of 3.2 million Euro.
February 17, 2022
Read more
Press Release: Biograil signs collaboration agreement with Janssen
Biograil has signed a Feasibility, Option and License Agreement with Janssen Biotech, Inc.
December 2, 2020
Read more
Press Release: Biograil announces – Sanner Ventures has joined Investor Syndicate
Biograil closing of a seed funding of 3 Million Euro
April 30, 2020
Read more
CEO Karsten Lindhardt shares vision for Biograil, by MEGATREND INVEST
CEO Karsten Lindhardt shares vision for Biograil, by MEGATREND INVEST
April 8, 2020
Read more
Press Release: Biograil Secures Seed Funding for Oral Delivery Device with Potential to Transform Market for Injectables
Biograil closing of a seed funding of 3 Million Euro
January 15, 2020
Read more